Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study
Abstract Introduction Although the efficacy of long‐acting injectable cabotegravir (CAB‐LA) for pre‐exposure prophylaxis (PrEP) is well‐known from clinical trials, research is needed to guide effective strategies for its implementation. We describe a qualitative study to assess perceptions and prefe...
Saved in:
| Main Authors: | Cristina Pimenta, Claudio G. Mann, Brenda Hoagland, Eduardo Carvalheira, Cristina Jalil, Marcos Benedetti, Nilo Fernandes, Carolina Coutinho, Emilia M. Jalil, Mayara Secco Torres Silva, Roberta Trefiglio, Alessandro Farias, Maria Paula G. Mourão, José Valdez Madruga, Josué N. deLima, Ronaldo Zonta, Gabrielle O'Malley, Valdilea G. Veloso, Beatriz Grinsztejn, Thiago S. Torres, for the ImPrEP CAB‐Brasil Study |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Journal of the International AIDS Society |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jia2.26493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
by: M Cristina Pimenta, et al.
Published: (2024-10-01) -
HIV‐1 testing in the context of expanding PrEP modalities
by: Urvi M. Parikh, et al.
Published: (2025-07-01) -
Weekly Text Messages to Support Adherence to Oral Pre-Exposure Prophylaxis (PrEP) Among Gay, Bisexual, and Other Cisgender Men Who Have Sex With Men (MSM) and Transgender Women: Pilot Randomized Controlled Trial Nested in PrEP Brasil Study
by: Luana Monteiro Spindola Marins, et al.
Published: (2025-07-01) -
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
by: Bridget Atuhaire, et al.
Published: (2024-12-01) -
Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study
by: Katherine L. Nelson, et al.
Published: (2025-07-01)